TY - JOUR
KW - Adult
KW - Buprenorphine/therapeutic use
KW - Chronic Disease/epidemiology
KW - Female
KW - Humans
KW - Insurance Claim Review
KW - Male
KW - Middle Aged
KW - Narcotic Antagonists/therapeutic use
KW - Opioid-Related Disorders/drug therapy
KW - Primary Health Care/organization & administration
KW - Retrospective Studies
KW - Socioeconomic Factors
AU - T. A. Rowe
AU - J. S. Jacapraro
AU - D. A. Rastegar
A1 - 
AB - BACKGROUND: Buprenorphine is an effective treatment for opioid dependence that can be provided in a primary care setting. Offering this treatment may also facilitate the identification and treatment of other chronic medical conditions. METHODS: We retrospectively reviewed the medical records of 168 patients who presented to a primary care clinic for treatment of opioid dependence and who received a prescription for sublingual buprenorphine within a month of their initial visit. RESULTS: Of the 168 new patients, 122 (73%) did not report having an established primary care provider at the time of the initial visit. One hundred and twenty-five patients (74%) reported at least one established chronic condition at the initial visit. Of the 215 established diagnoses documented on the initial visit, 146 (68%) were not being actively treated; treatment was initiated for 70 (48%) of these within one year. At least one new chronic medical condition was identified in 47 patients (28%) during the first four months of their care. Treatment was initiated for 39 of the 54 new diagnoses (72%) within the first year. CONCLUSIONS: Offering treatment for opioid dependence with buprenorphine in a primary care practice is associated with the identification and treatment of other chronic medical conditions.
BT - Addiction science & clinical practice
C5 - Healthcare Disparities; Opioids & Substance Use
CP - 1
CY - England
DO - 10.1186/1940-0640-7-22
IS - 1
JF - Addiction science & clinical practice
N2 - BACKGROUND: Buprenorphine is an effective treatment for opioid dependence that can be provided in a primary care setting. Offering this treatment may also facilitate the identification and treatment of other chronic medical conditions. METHODS: We retrospectively reviewed the medical records of 168 patients who presented to a primary care clinic for treatment of opioid dependence and who received a prescription for sublingual buprenorphine within a month of their initial visit. RESULTS: Of the 168 new patients, 122 (73%) did not report having an established primary care provider at the time of the initial visit. One hundred and twenty-five patients (74%) reported at least one established chronic condition at the initial visit. Of the 215 established diagnoses documented on the initial visit, 146 (68%) were not being actively treated; treatment was initiated for 70 (48%) of these within one year. At least one new chronic medical condition was identified in 47 patients (28%) during the first four months of their care. Treatment was initiated for 39 of the 54 new diagnoses (72%) within the first year. CONCLUSIONS: Offering treatment for opioid dependence with buprenorphine in a primary care practice is associated with the identification and treatment of other chronic medical conditions.
PP - England
PY - 2012
SN - 1940-0640; 1940-0632
SP - 22
T1 - Entry into primary care-based buprenorphine treatment is associated with identification and treatment of other chronic medical problems
T2 - Addiction science & clinical practice
TI - Entry into primary care-based buprenorphine treatment is associated with identification and treatment of other chronic medical problems
U1 - Healthcare Disparities; Opioids & Substance Use
U2 - 23186008
U3 - 10.1186/1940-0640-7-22
VL - 7
VO - 1940-0640; 1940-0632
Y1 - 2012
ER -